Skip to content

Cronos Group

US · CRON #3133 by market cap Listed 1970
3.04 -0.04 -1.30%
Periodic snapshot; not a real-time feed. · 2026-11-20 20:02

Recent news

  • Citron Founder, a Short-Selling Giant, on Trial: CEO of Cronos Group (CRON.US) Cross-Examined, Unveiling Details of Alleged 'Short-and-Smear' Scheme
    Zhitong Finance · 2026/5/13
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Community Health (CYH) and Cronos Group (CRON)
    TipRanks · 2026/9/28
  • Rating change
    Cronos Group (CRON) Gets a Hold From Bernstein
    TipRanks · 2026/1/14
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)
    TipRanks · 2026/8/12
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Genfit SA (GNFT) and Cronos Group (CRON)
    TipRanks · 2024/5/15
  • Rating change
    Bernstein Initiates Cronos Group(CRON.US) With Hold Rating
    Market Newswire · 2026/5/12
  • Rating change
    Jefferies Remains a Hold on Cronos Group (CRON)
    TipRanks · 2024/5/18
  • Rating change
    CIBC: Maintaining the Cronos Group (CRON.US) rating, adjusted from Outperformer to Outperformer rating, and adjusted the target price from $3.00 to $3.50.
    Zhitong Finance · 2024/5/15
  • Rating change
    Roth MKM Initiates Cronos Group(CRON.US) With Buy Rating
    Market Newswire · 2025/7/19
  • Cronos Completes Acquisition Of CanAdelaar, Europe's Largest Adult-Use Cannabis Company CRON.T
    Dow Jones · 2026/10/15
  • Rating change
    Analysts Have Conflicting Sentiments on These Healthcare Companies: Cronos Group (CRON), Relay Therapeutics (RLAY) and Century Therapeutics (IPSC)
    TipRanks · 2024/8/9
  • Rating change
    BofA Securities Maintains Cronos Group(CRON.US) With Sell Rating, Cuts Target Price to $1.65
    Market Newswire · 2025/4/8
  • Rating change
    B of A Securities: Maintaining the Cronos Group (CRON.US) rating, adjusted from below the market to below the market rating, and adjusted the target price from $2.00 to $2.50.
    Zhitong Finance · 2024/4/8
  • Earnings Flash (CRON) Cronos Group Inc. Reports Q1 Revenue $45.2M, Vs. FactSet Est of $42.2M
    MT Newswires · 2026/5/11
  • Rating change
    TD Cowen Initiates Cronos Group(CRON.US) With Buy Rating, Announces Target Price $3.28
    Market Newswire · 2026/2/24
  • Rating change
    BofA Securities Maintains Cronos Group(CRON.US) With Sell Rating, Cuts Target Price to $2
    Market Newswire · 2024/10/15
  • Rating change
    Analysts Offer Insights on Healthcare Companies: RegenXBio (RGNX), Cronos Group (CRON) and Boston Scientific (BSX)
    TipRanks · 2026/6/25
  • Rating change
    CCORF Initiates Cronos Group(CRON.US) With Buy Rating, Announces Target Price $3.14
    Market Newswire · 2026/1/27
  • TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.02
    Market Newswire · 2026/5/12
  • TD Cowen Maintains Cronos Group(CRON.US) With Buy Rating, Raises Target Price to $4.94
    Market Newswire · 2026/9/28
  • Cronos Group Announces Extension of Shr Repurchase Program to the Toronto Stk Exchange CRON.T
    Dow Jones · 2026/6/17

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-11-20 20:02:36 · For reference only, not investment advice and not tailored to your situation.

Cronos Group discussion 0 comments

Add a comment